[Clinical physiopathological studies on myocardial oxygen metabolism. 3. Myocardial oxygen metabolism during administration of coronary dilators].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001565:Benzoates / Q000494:pharmacology; D001572:Benzofurans / Q000494:pharmacology; D003327:Coronary Disease / Q000378:metabolism; D003374:Coumarins / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology; D005260:Female; D005707:Gallic Acid / Q000494:pharmacology; D006016:Glycolates / Q000494:pharmacology; D006331:Heart Diseases / Q000378:metabolism; D006801:Humans; D007022:Hypotension / Q000378:metabolism; D008171:Lung Diseases / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D010101:Oxygen Consumption; D011437:Propylamines / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology*; D014700:Verapamil / Q000494:pharmacology; D014970:Xanthines / Q000494:pharmacology
D001565:Benzoates; D001572:Benzofurans; D003374:Coumarins; D006016:Glycolates; D011437:Propylamines; D014665:Vasodilator Agents; D014970:Xanthines; D005707:Gallic Acid; D004176:Dipyridamole; D014700:Verapamil